﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article xml:lang="en" article-type="correction" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Korean J Physiol Pharmacol</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Physiology &#38; Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="publisher">Korean J. Physiol. Pharmacol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-4512</issn>
<issn pub-type="epub">2093-3827</issn>
<publisher>
<publisher-name>The Korean Physiological Society and The Korean Society of Pharmacology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4196/kjpp.22.161rt</article-id>
<article-id pub-id-type="publisher-id">kjpp-29-6-779</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zheng</surname><given-names>Wan</given-names></name>
<xref rid="aff1" ref-type="aff"/>
<xref rid="cor1" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Tianfa</given-names></name>
<xref rid="aff1" ref-type="aff"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wei</surname><given-names>Junping</given-names></name>
<xref rid="aff1" ref-type="aff"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yan</surname><given-names>Yani</given-names></name>
<xref rid="aff1" ref-type="aff"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Shanshan</given-names></name>
<xref rid="aff1" ref-type="aff"/>
</contrib>
</contrib-group>
<aff id="aff1">Department of Cardiovascular Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570102, <country>P.R. China</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence</bold>: Wan Zheng, E-mail: <email xlink:href="meol263@163.com">meol263@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>11</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>11</month>
<year>2025</year>
</pub-date>
<volume>29</volume>
<issue>6</issue>
<fpage>779</fpage>
<lpage>779</lpage>
<permissions>
<copyright-statement>Copyright &#169; Korean J Physiol Pharmacol</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" vol="27" page="209"/>
</article-meta>
</front>
<body>
<sec sec-type="other">
<title>Retraction to:</title>
<p>Korean J Physiol Pharmacol 2023;27(3):209-220.</p>
<p>Published online May 1, 2023 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4196/kjpp.2023.27.3.209">https://doi.org/10.4196/kjpp.2023.27.3.209</ext-link></p>
<p>Dear Editorial Board,</p>
<p>We are the authors of the manuscript titled &#8220;Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression&#8221; (2023;27(3):209-220. DOI:10.4196/KJPP.2023.27.3.209).</p>
<p>We are writing to formally submit a request for the retraction of this article.</p>
<p>Our team was notified by the Office of Scientific Research Integrity, Ministry of Education of the People&#8217;s Republic of China, that during their investigations into research misconduct, concerns were raised regarding potential academic misconduct in the aforementioned published paper. We take this matter with the utmost seriousness. Although our internal review is still ongoing, out of the highest respect for research integrity, academic norms, and to maintain the sanctity of the scientific record, we have decided to proactively retract this paper to eliminate any potential negative impact on the scientific community.</p>
<p>We sincerely apologize for any inconvenience and additional workload this retraction may cause your journal. We also acknowledge the stringent oversight provided by the Office of Scientific Research Integrity in upholding research integrity. This incident has served as a profound warning, prompting us to deeply reflect on the oversights and deficiencies in our research practices.</p>
<p>We hereby solemnly commit that in all future research work, we will **strictly adhere to all national regulations and guidelines concerning research integrity and scholarly conduct, uphold academic ethics, and prevent any form of academic misconduct.** We will enhance research integrity education for all team members and implement a more rigorous process for data management and manuscript preparation to ensure the authenticity, originality, and thoroughness of all our future research outcomes.</p>
<p>We fully understand and will respect any subsequent decisions made by your journal regarding this matter.</p>
<p>Thank you for your understanding and support.</p>
</sec>
</body>
</article>